Intrinsiqs

Is Niagen Bioscience Inc overvalued?

Niagen Bioscience Inc (NAGE) — key valuation metrics and fundamentals.

No verdict
Price
$3.21
Fair value
Current P/E
Normal P/E
Market cap
$253.7M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares NAGE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.